Cita APA (7a ed.)

Ghazi, N. G., Kirk, T. Q., Knape, R. M., & al, e. (2010). Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration? Dove Medical Press.

Cita Chicago Style (17a ed.)

Ghazi, Nicola G., Tyler Q. Kirk, Robert M. Knape, y et al. Is Monthly Retreatment with Intravitreal Bevacizumab (Avastin®) Necessary in Neovascular Age-related Macular Degeneration? Dove Medical Press, 2010.

Cita MLA (8a ed.)

Ghazi, Nicola G., et al. Is Monthly Retreatment with Intravitreal Bevacizumab (Avastin®) Necessary in Neovascular Age-related Macular Degeneration? Dove Medical Press, 2010.